Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
61.78
+2.40 (4.04%)
At close: Oct 22, 2025, 4:00 PM EDT
61.01
-0.77 (-1.25%)
After-hours: Oct 22, 2025, 5:16 PM EDT
Nektar Therapeutics Market Cap
Nektar Therapeutics has a market cap or net worth of $1.17 billion as of October 22, 2025. Its market cap has increased by 383.53% in one year.
Market Cap
1.17B
Enterprise Value
1.12B
1-Year Change
383.53%
Ranking
Category
Stock Price
$61.78
Market Cap Chart
Since December 1, 1998, Nektar Therapeutics's market cap has increased from $478.60M to $1.17B, an increase of 145.50%. That is a compound annual growth rate of 3.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 1.13B | 558.48% |
| Dec 31, 2024 | 171.50M | 59.09% |
| Dec 29, 2023 | 107.80M | -74.62% |
| Dec 30, 2022 | 424.80M | -82.96% |
| Dec 31, 2021 | 2.49B | -18.24% |
| Dec 31, 2020 | 3.05B | -19.69% |
| Dec 31, 2019 | 3.80B | -33.26% |
| Dec 31, 2018 | 5.69B | -39.50% |
| Dec 29, 2017 | 9.40B | 401.47% |
| Dec 30, 2016 | 1.88B | -16.61% |
| Dec 31, 2015 | 2.25B | 12.95% |
| Dec 31, 2014 | 1.99B | 51.06% |
| Dec 31, 2013 | 1.32B | 54.43% |
| Dec 31, 2012 | 853.40M | 33.30% |
| Dec 30, 2011 | 640.20M | -47.19% |
| Dec 31, 2010 | 1.21B | 39.56% |
| Dec 31, 2009 | 868.60M | 68.99% |
| Dec 31, 2008 | 514.00M | -16.91% |
| Dec 31, 2007 | 618.60M | -54.96% |
| Dec 29, 2006 | 1.37B | -4.78% |
| Dec 30, 2005 | 1.44B | -15.13% |
| Dec 31, 2004 | 1.70B | 122.51% |
| Dec 31, 2003 | 763.80M | 70.57% |
| Dec 31, 2002 | 447.80M | -56.04% |
| Dec 31, 2001 | 1.02B | -55.42% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 726.23B |
| Johnson & Johnson | 466.54B |
| AbbVie | 409.95B |
| UnitedHealth Group | 330.10B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.74B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 225.41B |